Abbott Laboratories

3. Abbott Laboratories (before the spinoff into AbbVie)

Total Ad Spend: $301.7 million
Television: $264 million
Magazine: $35 million
Other: $2.7 million

Blockbuster Humira was the driving force behind Abbott Laboratories ($9.2 billion in sales in 2012) and now holds that distinction for AbbVie ($ABBV), the brand-new spinoff that took all of Abbott's ($ABT) pharma assets. Even the current top-selling drug worldwide can benefit from some advertising.

In the spotlight


Humira for arthritis, $84.5 million
AndroGel, $80 million
Humira for Crohn's disease, $57.2 million


 

Abbott Laboratories
Read more on

Suggested Articles

AstraZeneca and Brazil have expanded their deal for a possible COVID-19 vaccine, this time to the tune of $360 million.

Novavax expects to churn out enough vaccines in 2021 to meet U.S. demand; experts slam the medical and political risks of Russia's unproven vaccine.

Novavax will have billions of doses of COVID-19 vaccine capacity next year and could single-handedly meet U.S. demand, executives said.